ÈESKÁ UROLOGIE / CZECH UROLOGY – 1 / 2018

31 Ces Urol 2018; 22(1): 27–31 PØEHLEDOVÝ ÈLÁNEK 13. Francomano D, Ilacqua A, Bruzziches R, Lenzi A, Aversa A. Effects of 5 year treatment with testo- sterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and meta- bolic syndrom. Urology. 2014; 83(1): 167–173. Dostupný také z http://reference.medscape.com/medline/ abstract/24139347?prt=true. 14. Shim JS, Kim JH, Yoon YS, et al. Serum testosterone levels are negatively correlated with internatio- nal prostate symptom score and transitional prostate volume. Dostupný z http://onlinelibrary.wiley.com/ doi/10.1111/luts.12150/full. 15. Meikle AW, Arver S, Dobs AS, et al. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. Urology. 1997; 49(2): 191–196. Využijte redakèního systému ACTAVIA pro zasílání Vašich rukopisù k publikaci